Finding new treatments for diabetic eye disease
Identification of Immunomodulators for Diabetic Retinopathy Therapeutics
This study is looking for new ways to protect the eyes of people with diabetes from a serious condition called diabetic retinopathy by understanding how inflammation harms eye cells, and it aims to find treatments that can help keep your vision safe.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10817715 on NIH RePORTER |
What this research studies
This research focuses on identifying immunomodulators that can help prevent diabetic retinopathy, a serious eye condition affecting many people with diabetes. The researchers are investigating how inflammation contributes to the damage of retinal cells and exploring potential therapies that target this inflammatory response. Using a mouse model of diabetes, they have discovered key molecules involved in the inflammatory process that leads to vision loss. By understanding these mechanisms, the goal is to develop new treatments that can protect the eyes of diabetic patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes or pre-diabetes who are at risk of developing diabetic retinopathy.
Not a fit: Patients without diabetes or those who do not have any risk factors for diabetic retinopathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that prevent or slow the progression of diabetic retinopathy, potentially preserving vision for many patients.
How similar studies have performed: Other research has shown promise in targeting inflammation for treating diabetic complications, suggesting that this approach could be effective.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Taylor, Patricia R — Case Western Reserve University
- Study coordinator: Taylor, Patricia R
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.